Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  ISIS Pharmaceuticals, Inc.    ISIS

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/31/2015 09/01/2015 09/02/2015 09/03/2015 09/04/2015 Date
50.18(c) 48.75(c) 51.75(c) 51.57(c) 52.1 Last
2 138 757 2 163 653 1 636 163 2 034 098 1 103 361 Volume
-2.64% -2.85% +6.15% -0.35% +1.03% Change
More quotes
Financials ($)
Sales 2015 284 M
EBIT 2015 -29,9 M
Net income 2015 -62,4 M
Finance 2015 997 M
Yield 2015 -
Sales 2016 280 M
EBIT 2016 -84,0 M
Net income 2016 -127 M
Finance 2016 1 301 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 18,2x
EV / Sales 2016 17,4x
Capitalization 6 186 M
More Financials
Company
Isis Pharmaceuticals, Inc. engages in the development and commercialization of antisense drug discovery platform.It operates through the Drug Discovery and Development segment which exploits a novel drug discovery platform created to generate a broad pipeline of first-in-class drugs for the company... 
Sector
Biotechnology & Medical Research
Calendar
09/10 | 09:10amPresentation
More about the company
Surperformance© ratings of ISIS Pharmaceuticals, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ISIS PHARMACEUTICALS, INC.
09/03 ISIS PHARMACEUTICALS : to Present at Upcoming Investor Conferences
08/12 ISIS PHARMACEUTICALS : AstraZeneca and Isis Pharmaceuticals to Discover and Deve..
08/12 ISIS PHARMACEUTICALS : Reports Financial Results And Highlights For Second Quart..
08/06 ISIS PHARMACEUTICALS : Excaliard Pharmaceuticals, Isis Pharmaceuticals Assigned ..
08/06 Isis Reveals Positive Data from KYNAMRO (mipomersen sodium) FOCUS FH Phase 3 ..
08/05 ISIS PHARMACEUTICALS : Reports Data from ISIS-TTR Rx in patients with Transthyre..
08/05 ISIS PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
08/04 ISIS PHARMACEUTICALS : beats 2Q profit forecasts
More news
Sector news : Biotechnology & Medical Research - NEC
09/03 MEDIVATION : Announces Participation at Upcoming Investor Conference
09/03 QUINTILES TRANSNATIONAL : CEO to Present at Morgan Stanley Global Healthcare Con..
09/03 QIAGEN NV : kit isolates high-quality RNA from exosomes in liquid biopsies
More sector news : Biotechnology & Medical Research - NEC
4-Traders Strategies on ISIS PHARMACEUTICALS, INC. 
2014A resistance as obstacle
More Strategies
News from SeekingAlpha
08/31 BIOTECH REVIEW (PART 2 OF 3) : New Coverage Of Some Mid-Caps With Update On Inte..
08/13 ISIS PHARMA STOCK DROPS ON GOOD NEWS : Re-Evaluating The Bull Case
08/10 3 Promising Biotechs Hobbled By First-Impression Issues
08/07 SHAKEN, NOT STIRRED : Is The 'Biotech Bubble' Beginning To Burst?
08/05 PREMARKET BIOTECH DIGEST : GBIM Soars On Celgene Deal, Superbugs, 3D Printed Dru..


Comments 
Advertisement
Chart ISIS PHARMACEUTICALS, INC.
Duration : Period :
ISIS Pharmaceuticals, Inc. Technical Analysis Chart | ISIS | US4643301090 | 4-Traders
Full-screen chart
Technical analysis trends ISIS PHARMACEUTIC...
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions